SK Biopharm and Latin American pharmaceutical giant establish joint venture to use AI to predict epilepsy - South Korean media

SK Biopharm, a drug development company, has formed a joint venture with Europharma, a major Brazilian pharmaceutical company, to commercialize an AI-based epilepsy management platform.